.png){kind=icon}
返回
Drug repurposing: progress, challenges and recommendations
.png){kind=icon}
PRE
AI
DOI：10.1038/nrd.2018.168.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Given the high attrition rates, substantial costs and slow pace of new drug discovery and development, repurposing of 'old' drugs to treat both common and rare diseases is increasingly becoming an attractive proposition because it involves the use of de-risked compounds, with potentially lower overall development costs and shorter development timelines. Various data-driven and experimental approaches have been suggested for the identification of repurposable drug candidates; however, there are also major technological and regulatory challenges that need to be addressed. In this Review, we present approaches used for drug repurposing (also known as drug repositioning), discuss the challenges faced by the repurposing community and recommend innovative ways by which these challenges could be addressed to help realize the full potential of drug repurposing.
Keyword:
AMYOTROPHIC-LATERAL-SCLEROSIS
3 RECEPTOR ANTAGONISM
KINASE INHIBITOR
GENE-EXPRESSION
SMALL MOLECULES
SRC KINASE
PHASE-II
DISEASE RELATIONSHIPS
SARACATINIB AZD0530
WIDE ASSOCIATION
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
101.8
论文数:
5.1K
被引数:
5.3W
机构
引用论文
Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors.png)
ACS CHEMICAL BIOLOGY
ACS CHEMICAL BIOLOGYIF3.8
PREAI
分享收藏分享收藏分享收藏Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity DatasetCANCER DISCOVERY
OAAI
CANCER DISCOVERYIF33.3
OAAI分享收藏The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumourgrowthEMBO JOURNALOAAI
EMBO JOURNALIF8.3
OAAI分享收藏
查看更多内容